ADVERTISEMENT

Consumer

US Consumer Health Sports Marketing: Opill/WNBA, Recover 180/NBA, Bucked Up/McGregor

US Consumer Health Sports Marketing: Opill/WNBA, Recover 180/NBA, Bucked Up/McGregor

Opill marketer Perrigo builds on marketing collaboration with WNA in partnership with Napheesa Collier; Bucked Up partners with MMA champion and entrepreneur Conor McGregor; and Recover 180 collaborates with NBA players.

Cosmetics Industry May Face Tariffs, Trade Agreement Challenges In New Trump Administration

Cosmetics Industry May Face Tariffs, Trade Agreement Challenges In New Trump Administration

Tariffs are expected again under a second Trump Administration and the future of the Americas Partnership for Economic Prosperity is uncertain, says the Personal Care Products Council, which will continue to push for regulatory alignment and lower trade barriers.

US Proposal To Remove Phenylephrine From OTC Monograph Could Stress-Test Streamlined Process

US Proposal To Remove Phenylephrine From OTC Monograph Could Stress-Test Streamlined Process

Proposed administrative order likely is first to prompt opposition from OTC industry or other stakeholders potentially delaying or deferring the agency’s expectation for moving its proposal to a deemed final order effective one year after it would be published.

Perrigo’s Formula To Drive Earnings Rebound Swings On Further Formula Business Recovery

Perrigo’s Formula To Drive Earnings Rebound Swings On Further Formula Business Recovery

“The infant formula business is recovering and we've taken actions to simplify and consumerize our business, but there's a lot more work to do,” says CEO Patrick Lockwood-Taylor as Perrigo’s announced latest results.

US Nutrition Market Business News: Boka Well, Beachbody/HSAs, Dr Pepper/Ghost, More

US Nutrition Market Business News: Boka Well, Beachbody/HSAs, Dr Pepper/Ghost, More

Beachbody offers supplement sales using health savings accounts; PlantX, Boka launches oral health supplements; supplements take Form from RTE meal provider Factor; LIV3 JV behind marketing SugarShield; Ghost among Keurig Dr Pepper brands; and Nutra-Med Packaging expands with Legacy Pharma.

CRN Urges Tighter NDI Enforcement, Offers Its OWL As Model For FDA’s Potential Mandatory List

CRN Urges Tighter NDI Enforcement, Offers Its OWL As Model For FDA’s Potential Mandatory List

Trade group ready to work hand-in-hand with agency and other supplement industry stakeholders on potential regulatory changes or improvements, says president and CEO Steve Mister. “None of them are upsetting the basic balance of things that DSHEA was attempting to do, but there are things with 30 years that we've identified that need to be kind of fixed.”

Challenge To US Homeopathic Drugs Regulation Rings Post-Chevron And OTC Monograph Bells

Challenge To US Homeopathic Drugs Regulation Rings Post-Chevron And OTC Monograph Bells

Supreme Court’s Loper Bright “decision is central to this case,” says Jonathan Emord, attorney representing Alliance for Natural Health USA and Meditrend Inc. in a complaint filed in US District Court for the District of Columbia.

In Emergency Rule, California Bans All THCs In Hemp Products: Industry Asks, Where’s The Fire?

In Emergency Rule, California Bans All THCs In Hemp Products: Industry Asks, Where’s The Fire?

California authorities say predominance of retailers licensed to sell hemp are compliant with ban published effective on 3 October through emergency regulation. But hemp industry’s contesting the regulation in state court, arguing state authorities inappropriately used emergency action to change state law on hemp products legislature passed in 2021.

Mucinex Promotes Romance To US Consumers, Launches Something To Chew On For Children

Mucinex Promotes Romance To US Consumers, Launches Something To Chew On For Children

Reckitt backs up prediction for strong sales during current quarter with advertising featuring a beauty queen and a line extension for Mucinex, one its strongest US consumer health product lines.

US FDA Keeps Cessation As ‘Gold Standard’ For NRT Indication As Critics Question Its Worth

US FDA Keeps Cessation As ‘Gold Standard’ For NRT Indication As Critics Question Its Worth

FDA’s OTC office director details a 2023 guidance as opening doors for NRT innovation at recent public meeting, but researchers and an industry executive note the most recent approval in the US for an innovative NRT was more than 20 years ago and say FDA isn’t allowing sufficient flexibility for approvals of new products or indications other than cessation related to quitting smoking.